Product
Patsnap Eureka
For R&D, Patsnap Eureka makes reading and utilizing patents & technical documents easy.
Patsnap Eureka AIR
Designed for self-driven R&D workflows. Generate viable solutions, solve complex R&D challenges, empower your innovation with AI.
Patsnap Eureka Materials
Designed for material experts only. Revolutionize your material R&D, from search, analyze, to developing new materials.
Feature
TechResearch
Generate reliable direction feasibility study reports for your R&D in just a few steps.
TechSeek
Discover and master advanced knowledge NOW. Basics, ideas, possibilities, all at once.
TechMind
As an expert in R&D Theories, TechMind can generates customized viable solutions instantly.
TechRisk
Analyze your overall solution with one click, know your potential R&D risks in advance.
TechMonitor
Get weekly tech updates, stay abreast of the latest tech innovations and key insights.
Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
41 results about "Sexual arousal" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
Sexual arousal (also sexual excitement) is typically the arousal of sexual desire during or in anticipation of sexual activity. A number of physiological responses occur in the body and mind as preparation for sexual intercourse and continue during it. Male arousal will lead to an erection, and in female arousal the body's response is engorged sexual tissues such as nipples, vulva, clitoris, vaginal walls and vaginal lubrication. Mental stimuli and physical stimuli such as touch, and the internal fluctuation of hormones, can influence sexual arousal.
Systems and methods for therapeutic treatments of various conditions of a female person
ActiveUS20130116503A1Improve gripPromoting pleasurePhysical therapies and activitiesMechanical/radiation/invasive therapiesMedicineSexual arousal
Systems and methods for interactive treatments of female sexual disorders are presented. A programmable sexual stimulation device is provided, which transmits and receives data relating to the use and function of the device. The sexual stimulation device may be programmed to implement a particular combination of mechanical actions which have been customized by a user or a health care professional involved in the treatment or preference of the user. The device may also collect data on the type of mechanical actions input by the user and transmit the data to a remote location for viewing by the user or the healthcare professional. The device may also communicate with external devices which aid in the treatment programs, such as audio or image display devices which can coordinate the function of the sexual stimulation device with the presentation of audio or visual information to provide additional sources of sexual arousal to the user.
Owner:OHMEA MEDICAL TECH
Compounds and methods for the treatment of urogenital disorders
The present invention provides methods for treating a variety of urogenital disorders, such as, for example, vaginismus, dyspareunia, vulvodynia (including vulvar vestibulitis), interstitial cystitis, nonspecific urethriris (i.e., nonspecific pain and / or burning of the urinary tract) and sexual dysfunctions, such as, for example, female sexual arousal disorders and female sexual orgasmic disorders, using a variety of compounds, including, but not limited to, NO donors, calcium channel blockers, cholinergic modulators, α-adrenergic receptor antagonists, β-adrenergic receptor agonists, phosphodiesterase inhibitors, cAMP-dependent protein kinase activators (e.g., cAMP mimetics), superoxide scavengers, potassium channel activators, estrogen-like compounds, testosterone-like compounds, benzodiazepines, adrenergic nerve inhibitors, antidiarrheal agents, HMG-CoA reductase inhibitors, smooth muscle relaxants, adenosine receptor modulators, adenylyl cyclase activators, endothelin receptor antagonists, bisphosphonates and cGMP-dependent protein kinase activators (e.g., cGMP mimetics).
Owner:STREHKEHN INT LTD
Male chastity device having a sensor for detecting prohibited behaviors
InactiveUS20110295156A1Discourage unwanted and/or prohibited behaviorsImprove securityElectrotherapyPerson identificationSensing dataMedicine
A male chastity device utilizes sensors to detect sexual arousal, sexual activity, and / or attempts to tamper with or remove the device. It reports sensed data and / or employs an aversive electric stimulus to discourage the detected unwanted behaviors. The male chastity apparatus includes a structural element wearable on male genital anatomy, and at least one sensor for detecting unwanted activity relating to the male genital anatomy. The apparatus can also include at least two electrodes capable of delivering aversive stimulation to the male genital anatomy. The at least two electrodes can also be capable of delivering pleasurable stimulation to the male genital anatomy. The structural element can also include electrodes for electrically preventing or electrically inhibiting removal of the structural element from the male anatomy.
Owner:ARTURI IRO
Peroxide compounds for the prevention and treatment of sexual dysfunction in humans
A composition and method for treatment or prevention of human sexual dysfunction are disclosed. The method contemplates the topical application to a genital organ of composition containing an effective sexual arousal-inducing amount of a peroxide compound. Preferred peroxide compounds include benzoyl peroxide and carbamide peroxide, and mixtures thereof.
Owner:MIDWEST RES LAB
Methods and compositions for treating male erectile dysfunction
InactiveUS7265091B2Peptide/protein ingredientsGenetic material ingredientsFemale Sexual Arousal DisorderNeurotrophin-3
The invention provides a method for preventing or treating male erectile dysfunction or female sexual arousal disorder by administering an effective amount of one or more factors from a group of factors including vascular endothelial growth factor, brain-derived neurotrophic factor, basic fibroblast growth factor, neurotrophin-3, neurotrophin-4, or angiopoietin-1, wherein the factor is a full length protein or a nucleic acid encoding the factor, or a functional derivative or fragment thereof, or an agent that enhances production and / or male erection or female sexual arousal stimulating function of the factor(s). Combinations, kits, and combinatorial methods are also provided.
Owner:RGT UNIV OF CALIFORNIA
Systems and methods for therapeutic treatments of various conditions of a female person
ActiveUS9011316B2Physical therapies and activitiesMechanical/radiation/invasive therapiesMedicineSexual arousal
Systems and methods for interactive treatments of female sexual disorders are presented. A programmable sexual stimulation device is provided, which transmits and receives data relating to the use and function of the device. The sexual stimulation device may be programmed to implement a particular combination of mechanical actions which have been customized by a user or a health care professional involved in the treatment or preference of the user. The device may also collect data on the type of mechanical actions input by the user and transmit the data to a remote location for viewing by the user or the healthcare professional. The device may also communicate with external devices which aid in the treatment programs, such as audio or image display devices which can coordinate the function of the sexual stimulation device with the presentation of audio or visual information to provide additional sources of sexual arousal to the user.
Owner:OHMEA MEDICAL TECH
Devices and methods for facilitating female sexual arousal, interest and satisfaction
A female sexual wellness device configured to provide stimulation frequencies targeting a specific nerve response of clitoral tissue. In one embodiment, the device can alternatively include a motor that creates an oscillatory air pressure wave.
Owner:AYTU WOMENS HEALTH LLC
Use of odorants to alter blood flow to the vagina
InactiveUS7067162B1Augment and lessen sexual arousalIncrease and decrease blood flowPowder deliveryBiocideInhalationSexual arousal
A non-invasive method of altering vaginal blood flow in a female individual to augment or lessen sexual arousal is provided. The method involves administering an individual odorant or odorant mixture for inhalation that is sufficient to alter vaginal blood flow of the female by about −20% to about +30% compared to a baseline vaginal blood flow without inhalation of the odorant. Also provided is a method for screening an odorant for its capacity to increase or decrease vaginal blood flow, and an article of manufacture, or kit, containing an odorant and instructions for its use in altering vaginal blood flow.
Owner:HIRSCH ALAN R
Composition for female sexual arousal
Compositions for female sexual arousal stimulating vaginal lubrication, vaginal and clitorial engorgement; said compositions contain aphrodisiacs, spermicidal and fungicidal components, may be applied intravaginally, extravaginally, and transdermally, and as a condom lubricant; and said compositions are contained in a water miscible cream base.
Owner:LONG JOSEPH F
Systems and methods for treating sexual disorders using electro-stimulation
ActiveUS9821163B2Spinal electrodesExternal electrodesAnatomical structuresFemale Sexual Arousal Disorder
Systems and methods are provided for treating a sexual disorder such as erectile dysfunction (ED) or female sexual arousal disorder (FSAD). An electrical stimulation system may include an implantable stimulation unit, an external patient controller, and an external physician controller. The implantable stimulation unit has an array of electrodes disposed on one or more flexible substrates configured to conform to a patient's anatomy at the pelvic plexus. Post-implantation, the physician controller may direct the stimulation unit to stimulate with select electrode(s) of the array to determine which electrode configuration provides optimal sexual arousal. The patient controller may be used to cause the stimulation unit to stimulate using the optimal electrode configuration at desired times.
Owner:ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL)
Use of odorants to alter blood flow to the vagina, and article of manufacture thereof
A non-invasive method of altering vaginal blood flow in a female individual to augment or lessen sexual arousal is provided. The method involves administering an individual odorant or odorant mixture for inhalation that is sufficient to alter vaginal blood flow of the female by about −20% to about +30% compared to a baseline vaginal blood flow without inhalation of the odorant. Also provided is a method for screening an odorant for its capacity to increase or decrease vaginal blood flow, and an article of manufacture, or kit, containing an odorant and instructions for its use in altering vaginal blood flow.
Owner:HIRSCH ALAN R
Composition for male & female sexual arousal
InactiveUS20040038984A1Improve sexual dysfunctionBiocidePharmaceutical delivery mechanismSexual arousalSperm
This inventon relates to compositions for stimulating sexual arousal in males and females and for male and female sexual arousal enhancement, and more particularly to the formaton of and treatment with said arousal, spermicidal and fungicidal composition to a male and female.
Owner:HARBECK MARIE H +1
Methods and compositions for enhancing female sexual arousal and treating female sexual dysfunction
InactiveUS20130210867A1Extended shelf lifeBiocidePharmaceutical delivery mechanismGynecologyArginine
Methods and compositions for enhancing female sexual arousal and treating female sexual dysfunction utilize L-arginine or equivalents and / or derivatives thereof, and an agent that enhances the activity of the L-arginine or equivalent thereof. These enhancing agents include niacin and / or nicotinamide. Niacin and / or nicotinamide, in combination with L-arginine or its equivalent allow a desired amount of nitric oxide to be delivered or generated at the female genitals in order to increase vasodilation and blood flow to the area to enhance sexual arousal and / or pleasure and to treat sexual dysfunction.
Owner:LIFE SCI ENHANCEMENT CORP
Lingerie-attached human arousal indicator
Temperature-sensitive mood stones or beads are incorporated into lingerie at positions that indicate sexual arousal to indicate by observation the state of arousal of the individual wearing the lingerie. In one embodiment, the mood beads are located adjacent the groin area for women's panties and at various erogenous zones of a brassiere, including cups and straps.
Owner:LANZO LAURA
Treatment of disorders of sexual arousal with local application of agents that increase membrane excitability
Owner:ROTHMAN STEVEN
Systems and methods for treating sexual disorders using electro-stimulation
Systems and methods are provided for treating a sexual disorder such as erectile dysfunction (ED) or female sexual arousal disorder (FSAD). An electrical stimulation system may include an implantable stimulation unit, an external patient controller, and an external physician controller. The implantable stimulation unit has an array of electrodes disposed on one or more flexible substrates configured to conform to a patient's anatomy at the pelvic plexus. Post-implantation, the physician controller may direct the stimulation unit to stimulate with select electrode(s) of the array to determine which electrode configuration provides optimal sexual arousal. The patient controller may be used to cause the stimulation unit to stimulate using the optimal electrode configuration at desired times.
Owner:ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL)
4',4''-substituted 3alpha-(diphenylmethoxy) tropane analogs for treatment of mental disorders
The present invention describes a method for the treatment of attention deficit hyperactivity disorder (ADHD), conduct disorder, alcohol addiction, tobacco addiction, nicotine addiction, parkinsonism including Parkinson's disease, female and male orgasmic disorders, female and male sexual arousal disorders, hypoactive sexual desire disorder, and disorders characterized by anxiety and / or depression. In this method, a therapeutically effective, nontoxic dose of a 4′,4″-substituted 3α-(diphenylmethoxy) tropane analog or a pharmaceutically acceptable salt thereof is administered to the patient in need of such treatment.
Owner:GOLDSTEIN STEVEN J
System and Method for Human Sexual Relationship Enhancement
A libido measurement icon displays messages related to a partner user's sexual arousal level on the display of a user's devices, such as Smartphone or tablet, having Internet connectivity. When a user or partner user activates the icon, the icon will display messages received from partner users related to the partner user's current level of sexual arousal and will allow a user to submit the user's own libido level (a “libido score”) to a partner user via the libido measurement system's messaging function.
Owner:OPEN ISLAND LLC
Traditional Chinese and western medicine combined compound preparation and application thereof
PendingCN114259555AImprove sexual painImprove lubrication barrierOrganic active ingredientsPeptide/protein ingredientsPhysiologyGlycerol
The invention provides a traditional Chinese and western medicine combined compound preparation which is applied to prevention and / or treatment of female sexual dysfunction and comprises epidermal growth factors, estrogen and glycerin. The invention further provides application of the compound preparation. The invention relates to the field of pharmaceutical preparations, in particular to the application in improving female sexual arousal and enhancing sexual desire and in products thereof, the application in improving female vaginal lubrication disorder and relieving vaginal dryness and in products thereof, the application in improving female sexual intercourse pain and improving sexual satisfaction and in products thereof and the application in preventing and / or treating female sexual dysfunction and in products thereof. The invention provides a basis for preventing and treating female sexual dysfunction by directly utilizing the compound preparation.
Owner:GENERAL HOSPITAL OF NINGXIA MEDICAL UNIV +1
A kind of collagen peptide lubricating liquid and preparation method thereof
ActiveCN107789611BGood biocompatibilityNo drug resistanceAntibacterial agentsOrganic active ingredientsSexual arousalUricotelic
Owner:FUJIAN NORMAL UNIV
Methods and Compositions for Treatment of Erectile Dysfunction
InactiveUS20090035221A1Effectively causingElcosanoid active ingredientsIn-vivo testing preparationsPenile TumescenceSexual arousal
A dosage chart for the treatment of achieving and maintaining male erectile response regardless of state of mind, occurrence of ejaculation or lack of sexual arousal of an object. The chart including a general, physical, and psychological conditions of the object; an age of the object; at least one pharmaceutical composition of one or more erection-producing agents; and a first corresponding dosage of the pharmaceutical composition to the age group and the general, physical, and psychological conditions of the object. The dosage chart further including observation of the object after receiving the corresponding dosage; and adjustment of a second dosage of the pharmaceutical composition.
Owner:MODULAR PROPERTIES
Rotary massaging stick
A rotary massaging stick having rotary massaging ball assemblies rotatable in reversed directions by a motor through a transmission gear train for stimulating the G point in the vagina of a woman to cause the woman to reach the climate of sexual excitement.
Owner:HSU YU
Methods and compositions for preventing and treating male erectile dysfunction and female sexual arousal disorder
InactiveUS7223406B2Increase productionEnhances male erectionBiocidePeptide/protein ingredientsFemale Sexual Arousal DisorderNeurotrophin-3
The invention provides a method for preventing or treating male erectile dysfunction or female sexual arousal disorder by administering an effective amount of one or more factors from a group of factors including vascular endothelial growth factor, brain-derived neurotrophic factor, basic fibroblast growth factor, neurotrophin-3, neurotrophin-4, or angiopoietin-1, wherein the factor is a full length protein or a nucleic acid encoding the factor, or a functional derivative or fragment thereof, or an agent that enhances production and / or male erection or female sexual arousal stimulating function of the factor(s). Combinations, kits, and combinatorial methods are also provided.
Owner:RGT UNIV OF CALIFORNIA
Erotic dream induction apparatus
InactiveUS20160331924A1Avoiding wakingChange pressureElectrocardiographyPneumatic massagePenisSexual arousal
An erotic dream induction apparatus includes an inflatable air bladder, such as a rubber balloon, to induce sexual arousal via genital stimulation. The air bladder is brought into contact with either the penis or vagina of the user, and / or is inserted into the anus and / or vagina of the user. In one embodiment, the air bladder is brought into contact with the penis, vagina, and / or anus of the user by being maintained in position near, against, or around the penis, vagina, and / or anus by means of straps or pockets in stimulation underwear, such that when the air bladder is inflated, the air bladder makes contact with at least a portion of the penis, vagina, and / or anus of the user. The air bladder is repeatedly inflated and deflated by means of pumps and / or valves.
Owner:VASAPOLLO CURZIO
Male chastity device having a sensor for detecting prohibited behaviors
InactiveUS9504419B2Discourage unwanted and/or prohibited behaviorsImprove securityElectrotherapyPerson identificationSensing dataMedicine
A male chastity device utilizes sensors to detect sexual arousal, sexual activity, and / or attempts to tamper with or remove the device. It reports sensed data and / or employs an aversive electric stimulus to discourage the detected unwanted behaviors. The male chastity apparatus includes a structural element wearable on male genital anatomy, and at least one sensor for detecting unwanted activity relating to the male genital anatomy. The apparatus can also include at least two electrodes capable of delivering aversive stimulation to the male genital anatomy. The at least two electrodes can also be capable of delivering pleasurable stimulation to the male genital anatomy. The structural element can also include electrodes for electrically preventing or electrically inhibiting removal of the structural element from the male anatomy.
Owner:ARTURI IRO
Treatment of female sexual dysfunction by compounds that positively modulate ampa-type glutamate receptors
InactiveUS20100069377A1Alleviating and decreasing sexual dysfunctionRelieve symptomsBiocideAnimal repellantsSexual dysfunctionPhysiology
The present invention provides methods of increasing sexual arousal and performance behaviors in female mammals by administration of a therapeutically acceptable amount of a positive modulator of an AMPA-type glutamate receptor.
Owner:RGT UNIV OF CALIFORNIA
Kombucha fermentation lubricant and preparation method thereof
ActiveCN107811958AGood biocompatibilityNo drug resistanceAntibacterial agentsCosmetic preparationsGlycerolHydroxyethyl Urea
The invention relates to a kombucha fermentation lubricant and a preparation method thereof. The kombucha fermentation lubricant is prepared from the following materials in parts by weight: 15-25 parts of kombucha fermentation broth, 30-40 parts of glycerinum, 0.5-1.5 parts of hyaluronic acid, 1-2 parts of water-soluble camellia oleosa seed oil, 0.3-0.5 part of Ylang essential oil, 0.5-1 part of hydroxyethyl urea, 0.5-1 part of kombucha fermentation film modifier, and 30-50 parts of deionized water. The hyaluronic acid lubricant disclosed by the invention is prepared from natural plants, is convenient to carry and use, and can effectively clean and improve the sexual arousal effect, thus being a lubricant product which can be used for a long time.
Owner:FUJIAN NORMAL UNIV
Methods and compositions for preventing and treating male erectile dysfunction and female sexual arousal disorder
InactiveUS20020160951A1Nervous disorderPeptide/protein ingredientsFemale Sexual Arousal DisorderPenile Tumescence
This invention relates generally to the field of urology. In particular, the invention provides a method for preventing or treating male erectile dysfunction or female sexual arousal disorder, which method comprises administering an effective amount of vascular endothelial growth factor (VEGF), brain-derived neurotrophic factor (BDNF), basic fibroblast growth factor (bFGF), or a functional derivative or fragment thereof, or a nucleic acid encoding said VEGF, BDNF or bFGF, or functional derivative or fragment thereof, or an agent that enhances production and / or erection or sexual arousal stimulating function of said VEGF or BDNF or bFGF to a mammal, wherein such prevention or treatment is desirable, thereby preventing or treating said male erectile dysfunction or female sexual arousal disorder in said mammal. Combinations, combinatorial methods and kits for preventing or treating male erectile dysfunction or female sexual arousal disorder are also provided.
Owner:RGT UNIV OF CALIFORNIA
Treatment of disorders of sexual arousal with local application of agents that increase membrane excitability
ActiveUS20190192493A1Enhancing sexual arousalIncrease cell membrane excitabilityInorganic active ingredientsAmine active ingredientsMale genitaliaSexual dysfunction
Compositions and methods for stimulating erogenous zones of female and male subjects are disclosed. More particularly, the present disclosure relates to compositions for topical application to the female and male genitalia that increase cell membrane excitability and to methods of using the compositions for treating sexual dysfunction and enhancing sexual arousal and facilitating orgasm.
Owner:ROTHMAN STEVEN
Methods and compositions for preventing and treating male erectile dysfunction and female sexual arousal disorder
InactiveUS20040180830A1Peptide/protein ingredientsGenetic material ingredientsFemale Sexual Arousal DisorderPenile Tumescence
This invention relates generally to the field of urology. In particular, the invention provides a method for preventing or treating male erectile dysfunction or female sexual arousal disorder, which method comprises administering an effective amount of vascular endothelial growth factor (VEGF), brain-derived neurotrophic factor (BDNF), basic fibroblast growth factor (bFGF), or a functional derivative or fragment thereof, or a nucleic acid encoding said VEGF, BDNF or bFGF, or functional derivative or fragment thereof, or an agent that enhances production and / or erection or sexual arousal stimulating function of said VEGF or BDNF or bFGF to a mammal, wherein such prevention or treatment is desirable, thereby preventing or treating said male erectile dysfunction or female sexual arousal disorder in said mammal. Combinations, combinatorial methods and kits for preventing or treating male erectile dysfunction or female sexual arousal disorder are also provided.
Owner:RGT UNIV OF CALIFORNIA
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com